Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomesJulian Musa, Thomas G. P. Grünewald, Maximilian M. L. Knott et al.|Nature Communications|2019Cited by 72
Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV600E inhibition in melanomaBatool Shannan, Alexander Roesch, Johann Matschke et al.|European Journal of Cancer|2019Cited by 26